Bob Schroff
Bob has 27 years of post-doctoral experience in university, government, biotechnology and pharmaceutical settings where he has shown the ability to take cutting edge technologies from the laboratory setting to the stage of commercial formulations capable of demonstrating efficacy in clinical evaluations.
He has an undergraduate degree in Life Sciences from the University of Missouri, a PhD in Immunology from Wake Forest University and an MBA from the University of Washington. His work has resulted in 70 scientific publications, including the original publication of the AIDS syndrome in the New England Journal of Medicine while at UCLA, and the first clinical trials of monoclonal antibodies while at the National Cancer Institute.